Daniel Johnson

National Institute of Allergy and Infectious Diseases · US

Area of research

Oncology · Virology

Research interest

Research focused on Tuberculosis and Pharmacokinetics, with related work in Raltegravir, Disease, Efavirenz. Notable publications include 'Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives', 'Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines', and 'Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose'.

h-index

—

citations

335

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives

The Lancet Infectious Diseases 2017cited by 176position: middledoi

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines

Clinical Infectious Diseases 2015cited by 125position: middledoi

Genetic and Non-Genetic Determinants of Raltegravir Penetration into Cerebrospinal Fluid: A Single Arm Pharmacokinetic Study

PLoS ONE 2013cited by 13position: firstdoi

Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose

British Journal of Clinical Pharmacology 2012cited by 21position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

David W. Haas · University of Alabama at Birmingham3 papers (2012–2017)Edward P. Acosta · University of Alabama at Birmingham Hospital2 papers (2012–2013)Danielle Richardson · Indiana University School of Medicine1 papers (2013–2013)Sudha Srinivasan · National Institute of Allergy and Infectious Diseases1 papers (2017–2017)Jamshed Bomanji · University of London1 papers (2015–2015)Markus Maeurer · Jena University Hospital1 papers (2015–2015)Michael E. Urbanowski · Walter Reed National Military Medical Center1 papers (2017–2017)Nimisha Chaturvedi · University of Edinburgh1 papers (2017–2017)— · 1 papers (2015–2015)— · 1 papers (2013–2013)Peter Mwaba · London School of Hygiene & Tropical Medicine1 papers (2015–2015)— · 1 papers (2012–2012)Marco Schito · National Institute of Allergy and Infectious Diseases1 papers (2015–2015)Nathan Kapata · Centre for Infectious Disease Research in Zambia1 papers (2015–2015)— · 1 papers (2012–2012)— · 1 papers (2013–2013)Erwin Schurr · McGill University Health Centre1 papers (2017–2017)Lia D’Ambrosio · McGill University Health Centre1 papers (2015–2015)Ruth McNerney · London School of Hygiene & Tropical Medicine1 papers (2015–2015)— · 1 papers (2015–2015)